BridgeBio Pharma seeks a Skeletal Dysplasia Account Manager to lead the launch of Infigratinib for achondroplasia, driving clinical partnerships with providers and families across the Northeast. The role requires deep therapeutic knowledge, a hunter mentality, and the ability to navigate multidisciplinary teams.
Ideal candidates will have 8–10 years in pharma/biotech with 4+ years in rare diseases, strong account management skills, extensive travel readiness, and a proven track record in product
#J-18808-Ljbffr